Intermediate hepatocellular carcinoma: How to choose the best treatment modality?-Reference-Cited by-同舟云学术

Intermediate hepatocellular carcinoma: How to choose the best treatment modality?

Published:2015 Issue:9 Volume:7 Page:1184
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:en
Short-container-title:WJH

Author:

Di Costanzo Giovan Giuseppe

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference93 articles.

1. World Health Organization. International Agency for Research in Cancer Globocan 2008: Cancer incidence and mortality worldwide; Available from: http://globocan.iarc.fr.

2. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

3. Prognosis of Primary Hepatocellular Carcinoma

4. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma

5. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada;Cancer Treatment Reviews;2023-04

2. Synergetic Thermal Therapy for Cancer: State-of-the-Art and the Future;Bioengineering;2022-09-15

3. Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy;Cancers;2021-10-30

4. Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2);Liver Cancer;2021

5. Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma;Frontiers in Oncology;2020-11-04